424 related articles for article (PubMed ID: 25644510)
1. Oncogenic KRAS promotes malignant brain tumors in zebrafish.
Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR
Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510
[TBL] [Abstract][Full Text] [Related]
2. Cre/loxP-regulated transgenic zebrafish model for neural progenitor-specific oncogenic Kras expression.
Seok SH; Na YR; Han JH; Kim TH; Jung H; Lee BH; Emelyanov A; Parinov S; Park JH
Cancer Sci; 2010 Jan; 101(1):149-54. PubMed ID: 19961491
[TBL] [Abstract][Full Text] [Related]
3. An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.
Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Parinov S; Gong Z
Dis Model Mech; 2012 Jan; 5(1):63-72. PubMed ID: 21903676
[TBL] [Abstract][Full Text] [Related]
4. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.
Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Lam SH; Mathavan S; Parinov S; Gong Z
Dis Model Mech; 2011 Nov; 4(6):801-13. PubMed ID: 21729876
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas.
Park SW; Davison JM; Rhee J; Hruban RH; Maitra A; Leach SD
Gastroenterology; 2008 Jun; 134(7):2080-90. PubMed ID: 18549880
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
7. mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells.
Komatsu N; Fujita Y; Matsuda M; Aoki K
Oncogene; 2015 Nov; 34(45):5607-16. PubMed ID: 25703330
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models.
Chew TW; Liu XJ; Liu L; Spitsbergen JM; Gong Z; Low BC
Oncogene; 2014 May; 33(21):2717-27. PubMed ID: 23812423
[TBL] [Abstract][Full Text] [Related]
9. KRAS(G12V) enhances proliferation and initiates myelomonocytic differentiation in human stem/progenitor cells via intrinsic and extrinsic pathways.
Fatrai S; van Gosliga D; Han L; Daenen SM; Vellenga E; Schuringa JJ
J Biol Chem; 2011 Feb; 286(8):6061-70. PubMed ID: 21169357
[TBL] [Abstract][Full Text] [Related]
10. Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult.
Yao Y; Sun S; Wang J; Fei F; Dong Z; Ke AW; He R; Wang L; Zhang L; Ji MB; Li Q; Yu M; Shi GM; Fan J; Gong Z; Wang X
Cancer Res; 2018 Oct; 78(19):5548-5560. PubMed ID: 30065049
[TBL] [Abstract][Full Text] [Related]
11. Inducible Intestine-Specific Expression of kras
Lu JW; Raghuram D; Fong PA; Gong Z
Neoplasia; 2018 Dec; 20(12):1187-1197. PubMed ID: 30390498
[TBL] [Abstract][Full Text] [Related]
12. Ras effector mutant expression suggest a negative regulator inhibits lung tumor formation.
Vandal G; Geiling B; Dankort D
PLoS One; 2014; 9(1):e84745. PubMed ID: 24489653
[TBL] [Abstract][Full Text] [Related]
13. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
14. Expression of KRASG12V in Zebrafish Gills Induces Hyperplasia and CXCL8-Associated Inflammation.
Shive HR; West RR; Embree LJ; Sexton JM; Hickstein DD
Zebrafish; 2015 Jun; 12(3):221-9. PubMed ID: 25798815
[TBL] [Abstract][Full Text] [Related]
15. p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model.
Chow HY; Jubb AM; Koch JN; Jaffer ZM; Stepanova D; Campbell DA; Duron SG; O'Farrell M; Cai KQ; Klein-Szanto AJ; Gutkind JS; Hoeflich KP; Chernoff J
Cancer Res; 2012 Nov; 72(22):5966-75. PubMed ID: 22983922
[TBL] [Abstract][Full Text] [Related]
16. Zebrafish rhabdomyosarcoma reflects the developmental stage of oncogene expression during myogenesis.
Storer NY; White RM; Uong A; Price E; Nielsen GP; Langenau DM; Zon LI
Development; 2013 Jul; 140(14):3040-50. PubMed ID: 23821038
[TBL] [Abstract][Full Text] [Related]
17. Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey.
Park JT; Johnson N; Liu S; Levesque M; Wang YJ; Ho H; Huso D; Maitra A; Parsons MJ; Prescott JD; Leach SD
Oncogene; 2015 May; 34(21):2801-6. PubMed ID: 25065594
[TBL] [Abstract][Full Text] [Related]
18. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
19. Development of a conditional liver tumor model by mifepristone-inducible Cre recombination to control oncogenic kras V12 expression in transgenic zebrafish.
Nguyen AT; Koh V; Spitsbergen JM; Gong Z
Sci Rep; 2016 Jan; 6():19559. PubMed ID: 26790949
[TBL] [Abstract][Full Text] [Related]
20. Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system.
Liu S; Leach SD
Methods Cell Biol; 2011; 105():367-81. PubMed ID: 21951538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
